Investor Presentation • Nov 7, 2025
Investor Presentation
Open in ViewerOpens in native device viewer


3Q-25 & 9M-25 Results

THIS DOCUMENT IS BEING PROVIDED TO YOU SOLELY FOR YOUR INFORMATION. THIS DOCUMENT, WHICH WAS PREPARED BY BANCA MONTE DEI PASCHI DI SIENA S.P.A. (THE "COMPANY" OR "BMPS" AND TOGETHER WITH ITS CONSOLIDATED SUBSIDIARIES, THE "GROUP"), IS PRELIMINARY IN NATURE AND MAY BE SUBJECT TO UPDATING, REVISION AND AMENDMENT. IT MAY NOT BE REPRODUCED IN ANY FORM, FURTHER DISTRIBUTED OR PASSED ON, DIRECTLY OR INDIRECTLY, TO ANY OTHER PERSON, OR REPUBLISHED IN ANY MANNER, IN WHOLE OR IN PART, FOR ANY PURPOSE. ANY FAILURE TO COMPLY WITH THESE RESTRICTIONS MAY CONSTITUTE A VIOLATION OF APPLICABLE LAWS AND VIOLATE THE COMPANY'S RIGHTS.
IMPORTANT: You must read the following before continuing. The following applies to this document, the oral presentation of the information in this document by the Company or any person on behalf of the Company, and any question-and-answer session that follows the oral presentation (collectively, the "Information"). In accessing the Information, you agree to be bound by the following terms and conditions.
This document was prepared by the Company solely for information purposes and for use in presentations of the Group's strategies and financials. The information contained herein provides a summary of the Group's 3Q 2025 financial statements and is not complete. 3Q 2025 complete interim financial statements will be available on the Company's website at www.gruppomps.it.
The information, statements and opinions contained in this presentation are for information purposes only and do not constitute (and are not intended to constitute) an offer of securities for sale, or solicitation of an offer to purchase or subscribe securities, nor shall it or any part of it form the basis of or be relied upon in connection with or act as any inducement or recommendation to enter into any contract or commitment or investment decision whatsoever. Neither this document nor any part of it nor the fact of its distribution may form the basis of, or be relied upon in connection with, any contract or investment decision in relation thereto. EachAny recipient is therefore responsible for their his own independent investigations and assessments regarding the risks, benefits, adequacy and suitability of any operation carried out after the date of this document.
Any securities referred to herein have not been registered and will not be registered in the United States under the U.S. Securities Act of 1933, as amended (the "Securities Act") or under the securities laws of any State or other jurisdiction of the United States or in United Kingdom, Australia, Canada or Japan or any other jurisdiction where such an offer or solicitation would be unlawful (the "Other Countries"). No securities may be offered or sold in the United States unless such securities are registered under the Securities Act, or an exemption from the registration requirements of the Securities Act is available. The Company does not intend to register or conduct any public offer of securities in the United States or in Other Countries. This document does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States or in Other Countries.
To the extent applicable, any industry and market data contained in this document has come from official or third-party sources. Third-party industry publications, studies and surveys generally state that the data contained therein has been obtained from sources believed to be reliable, but that there is no guarantee of the fairness, quality, accuracy, relevance, completeness or sufficiency of such data. The Company has not independently verified such data contained therein. In addition, some industry and market data contained in this document may come from the Company's own internal research and estimates, based on the knowledge and experience of the Company's management in the market in which the Company operates. Any such research and estimates, and their underlying methodology and assumptions, have not been verified by any independent source for accuracy or completeness and are subject to change without notice. Accordingly, undue reliance should not be placed on any of the industry or market data contained in this document.
This document may include certain forward-looking statements, projections, objectives and estimates reflecting the current views of the management of the Company and the Group with respect to future events. Forward-looking statements, projections, objectives, estimates and forecasts are generally identifiable by the use of the words "may", "will", "should", "plan", "expect", "anticipate", "estimate", "believe", "intend", "project", "goal" or "target" or the negative of these words or other variations on these words or comparable terminology. These forward-looking statements include, but are not limited to, all statements other than statements of historical facts, including, without limitation, those regarding the Company's and/or Group's future financial position and results of operations, strategy, plans, objectives, goals and targets and future developments in the markets where the Group participates or is seeking to participate. Any forward-looking statements in this document are subject to a number of risks and uncertainties. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements as a prediction of actual results. The Group's ability to achieve its projected objectives or results is dependent on many factors which are outside the Group's control. Actual results may differ materially from those projected or implied in the forward-looking statements. Such forward-looking information involves risks and uncertainties that could significantly affect expected results and is based on certain key assumptions. Moreover, such forward-looking information contained herein has been prepared on the basis of a number of assumptions which may prove to be incorrect and, accordingly, actual results may vary. All forward-looking statements included herein are based on information available to the Company as at the date hereof. The Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law.
Neither the Company nor any member of the Group nor any of its or their respective representatives, directors, or employees shall be liable at any time in connection with this presentation or any of its contents for any damages including, but not limited to, loss of profits or loss of opportunity, or any other liability whatsoever which may arise in connection with any use and/or reliance placed on this presentation. The Company, the Group and their representatives undertake no obligation to provide the recipients with access to any additional information or to update or revise this document or to correct any inaccuracies or omissions contained herein that may become apparent. This presentation shall remain the property of the Company.
Pursuant to paragraph 2, article 154-bis of the Consolidated Finance Act, the Financial Reporting Officer, Mr. Andrea Francesco Maffezzoni, declares that the accounting information contained in this document corresponds to the document results, books and accounting records.





Balance sheet figures do not include the contribution of Mediobanca, for comparison purposes
Income statement data refer only to MPS, with the consolidation of economic figures of Mediobanca starting from 4Q25 results












• 9M-25 commercial performance confirms the strength of MPS's franchise and clear focus on key strategic areas: total commercial savings up by more than €10bn y/y, WM gross inflows up +18% y/y, new retail mortgages granted in 9 months at €4.8bn, 2.2x vs 9M-24, new consumer finance up +17% y/y






• Net customer loans at €65.3bn, up +5.2% since Dec-24, driven by strong commercial activity in key strategic segments, retail and SME loans; positive dynamic also in 3Q-25


• Total commercial savings up by more than €7bn since December 2024 (+4.3%), with 3Q-25 solid contribution (€+3.3bn), driven by all components





• 3Q-25 fees at €382m, growing +7.4% vs 3Q-24, thanks to both strong WM fees performance, with +10.6% y/y dynamics, and commercial banking fees up +4.5% y/y, sustained by a clear commercial focus on key strategic areas; quarterly trend impacted by typical third-quarter seasonality


• 9M-25 total fees at €1,185m, up +8.5% y/y, thanks to a solid growth in wealth management and advisory fees (+12.8% y/y), and with a positive dynamics also in commercial banking fees (+4.4% y/y), confirming the strength and the potential of the network



• 3Q-25 operating costs at €468m, -0.6% q/q and almost stable y/y thanks to strong discipline in managing Non-HR costs (-2.4% q/q and -6.1% y/y) offsetting the impact of labour contract renewal and increase of variable remuneration pool on HR costs





• 9M-25 operating costs at €1,411m, up +1.4% y/y with the impact of the renewal of the labour contract and variable remuneration pool increase partially offset by the effective management of Non-HR costs













Sound liquidity position with LCR at 159% and NSFR at 131% and ECB funding on total liabilities at 7%



• CET1 FL at a solid level of 16.9% including the preliminary impact of Mediobanca transaction, confirming best-in-class capital buffer, providing strategic flexibility



Key messages




Consolidated position as a leading Italian player… … and reached scale at European level
in the Italian banking market (1)
8%
Loans market share (2)
~€8bn
Revenues (3)
~€3bn
Adj. net profit (3)
€125bn
Net customer Loans (4)
€291bn
Total Commercial Savings (5)
Ranking by market cap (6) (€bn, Eurozone banks)



RETAIL & COMMERCIAL BANKING
CONSUMER FINANCE
ASSET GATHERING & WEALTH MANAGEMENT
HNWI PRIVATE BANKING
CORPORATE & INVESTMENT BANKING
INSURANCE & ASSET MANAGEMENT









Office



(13%)














Set-up a Steering Committee to grant full consistency with the strategic and industrial Transaction rationale
Defined a Combination Program made by two main phases
Set a Project timeline which foresees the completion of Phase 1 by Q1 2026 and Phase 2 by 2026 year end
Confirmed expected outside-in synergies enabled by

~14% RoTE (%) (1)
100% Payout ratio (%)
16.9% CET1 ratio (%)
Financial benefits
Value creation for all stakeholders
A unique investment opportunity in the banking landscape with a double-digit dividend yield, one of the highest in the European banking sector


| January 24th | Deal announcement and MPS Notice pursuant to Art. 102 | ✓ | |||
|---|---|---|---|---|---|
| April 17th | EGM approval of the capital increase to support Mediobanca acquisition (86% favorable vote) |
||||
| End of June – July 2nd | Release of Supervisory authorities' prior authorizations and approval of the Offer Document by Consob |
✓ ✓ |
|||
| September 22nd | Closing of the reopening period with 86% of Mediobanca shares being tendered |
||||
| October 28th | Mediobanca AGM and new BoD appointment |
✓ | |||
| December 1st | Mediobanca AGM to approve amendments to the company's Articles of Association(1) |
||||
| By 1Q26 | Capital Markets Day and combined Business Plan | ||||
| By 2026 | Roll-out of target model | steps |






| Dec-24 | Mar-25 | Jun-25 | Sep-25 | |
|---|---|---|---|---|
| Convertible DTAs | 0.4 | 0.4 | 0.4 | 0.5 |
| DTAs on Tax loss carryforwards | 1.5 | 1.6 | 1.7 | 1.8 |
| Other non-convertible DTAs | 0.6 | 0.6 | 0.5 | 0.7 |
| Total on balance sheet DTAs | 2.4 | 2.5 | 2.6 | 3.0 |
| DTAs not recorded in balance sheet |
1.6 | 1.4 | 1.3 | 1.1 |

| Dec-24 | Mar-25 | Jun-25 | Sep-25 | |
|---|---|---|---|---|
| Alken civil litigation (2nd degree positive) |
0,45 | 0,45 | 0,45 | 0,45 |
| Other civil litigations |
0,22 | 0,22 | 0,22 | 0,22 |
| Criminal proceedings |
0,67 | 0,51 | 0,48 | 0,48 |
| Extrajudicial claims |
0,0 | 0,0 | 0,0 | 0,0 |

| (€m) | 3Q-25 | 2Q-25 | 3Q-24 | 9M-25 | 9M-24 | 3Q-25/ 2Q- 25 (%) |
3Q-25/ 3Q- 24 (%) |
- 9M-25/ 9M-24 (%) |
|---|---|---|---|---|---|---|---|---|
| Net Interest Income | 544 | 551 | 596 | 1,638 | 1,768 | -1.3% | -8.7% | -7.4% |
| Net fees and commission income | 382 | 405 | 356 | 1,185 | 1,092 | -5.5% | +7.4% | +8.5% |
| Core Revenues | 926 | 956 | 952 | 2,823 | 2,860 | -3.1% | -2.7% | -1.3% |
| Profit (loss) of equity-accounted investments (AXA) | 19 | 18 | 27 | 51 | 54 | +3.3% | -30.2% | -5.4% |
| Financial revenues (1) | 52 | 70 | 24 | 174 | 113 | -25.2% | n.m. | +54.4% |
| Other operating net income | 3 | 3 | 5 | 6 | 11 | -12.9% | -45.0% | -46.4% |
| Operating Income | 1,000 | 1,047 | 1,007 | 3,054 | 3,037 | -4.5% | -0.7% | +0.5% |
| Personnel expenses | -320 | -319 | -310 | -960 | -918 | +0.3% | +3.4% | +4.6% |
| Other administrative expenses | -109 | -111 | -116 | -333 | -348 | -1.4% | -5.3% | -4.3% |
| Depreciations/amortisations and net impairment losses on PPE | -39 | -41 | -42 | -118 | -127 | -4.9% | -8.3% | -6.9% |
| Operating Costs | -468 | -471 | -467 | -1,411 | -1,392 | -0.6% | +0.2% | +1.4% |
| Gross operating profit | 532 | 576 | 539 | 1,643 | 1,645 | -7.7% | -1.4% | -0.2% |
| Net impairment losses for credit risk | -79 | -84 | -96 | -254 | -300 | -5.9% | -17.8% | -15.4% |
| Net impairment losses for other financial assets | 0 | -3 | -1 | 0 | -6 | n.m. | n.m. | n.m. |
| Net operating profit | 453 | 488 | 442 | 1,389 | 1,339 | -7.3% | +2.4% | +3.7% |
| Net gains/losses on equity investments, PPE and intangible assets at FV, and disposal of investments | 1 | -5 | 2 | -2 | -27 | n.m. | -66.7% | -92.3% |
| Systemic funds contribution | 0 | 0 | 0 | 0 | -75 | n.m. | n.m. | n.m. |
| DTA Fee | -14 | -14 | -15 | -43 | -46 | +0.7% | -6.2% | -6.1% |
| Net accruals to provisions for risks and charges | -2 | -1 | -22 | -28 | -37 | n.m. | -88.6% | -22.5% |
| Restructuring costs / one-off costs | -5 | -8 | -17 | -21 | -58 | -36.5% | -67.2% | -64.4% |
| Costs of extraordinary operations | 0 | 0 | - | -1 | 0 | n.m. | n.m. | n.m. |
| Pre-tax profit (loss) | 431 | 460 | 390 | 1,288 | 1,096 | -6.2% | +10.4% | +17.5% |
| Income taxes | 43 | 20 | 16 | 78 | 470 | n.m. | n.m. | -83.3% |
| Profit (loss) for the period | 474 | 479 | 407 | 1,366 | 1,566 | -1.1% | +16.5% | -12.7% |


| (€m) | Sep-25 |
|---|---|
| Total Revenues | 5,732 |
| Personnel expenses | -1,596 |
| Other administrative expenses | -805 |
| Depreciations/amortisations and net impairment losses on PPE | -206 |
| Operating Costs | -2,607 |
| Gross operating profit | 3,126 |
| Net impairment losses for credit risk | -422 |
| Net impairment losses for other financial assets | 1 |
| Net operating profit | 2,704 |
| Non operating items | -164 |
| Profit (Loss) for the period before tax | 2,540 |
| Income tax for the period | -200 |
| Net profit (loss) for the period | 2,340 |
| Net profit (loss) attributable to non-controlling interests | 45 |
| Profit (loss) for the period | 2,295 |

| Dec-24 | Mar-25 | Jun-25 | Sep-25 | QoQ% | YtD% | MPS+MB Sep-25 |
|
|---|---|---|---|---|---|---|---|
| Loans to Central banks | 565 | 660 | 644 | 671 | 4.2% | 18.7% | 1,114 |
| Loans to banks | 2,068 | 1,921 | 1,716 | 2,089 | 21.7% | 1.0% | 6,746 |
| Loans to customers | 77,310 | 78,631 | 80,530 | 80,705 | 0.2% | 4.4% | 140,679 |
| Securities assets | 17,447 | 19,024 | 18,967 | 18,833 | -0.7% | 7.9% | 44,598 |
| Tangible and intangible assets | 2,298 | 2,274 | 2,251 | 2,243 | -0.4% | -2.4% | 7,778 |
| Other assets | 22,913 | 22,070 | 21,466 | 23,039 | 7.3% | 0.5% | 37,170 |
| Total Assets | 122,602 | 124,580 | 125,574 | 127,580 | 1.6% | 4.1% | 238,085 |
| Dec-24 | Mar-25 | Jun-25 | Sep-25 | QoQ% | YtD% | MPS+MB Sep-25 |
|
|---|---|---|---|---|---|---|---|
| Deposits from customers | 83,544 | 84,887 | 84,228 | 86,377 | 2.6% | 3.4% | 121,259 |
| Securities issued | 10,428 | 9,707 | 10,280 | 10,461 | 1.8% | 0.3% | 43,975 |
| Deposits from central banks | 8,511 | 8,010 | 8,009 | 8,520 | 6.4% | 0.1% | 8,575 |
| Deposits from banks | 1,301 | 1,854 | 2,250 | 1,977 | -12.1% | 52.0% | 14,292 |
| Other liabilities | 7,169 | 8,072 | 9,336 | 8,303 | -11.1% | 15.8% | 20,924 |
| Group net equity | 11,649 | 12,049 | 11,470 | 11,941 | 4.1% | 2.5% | 26,742 |
| Non-controlling interests | 0 | 0 | 0 | 0 | 0.0% | -33.3% | 2,318 |
| Total Liabilities | 122,602 | 124,580 | 125,574 | 127,580 | 1.6% | 4.1% | 238,085 |


| Dec-24 | Mar-25 | Jun-25 | Sep-25 | QoQ% | YtD% | MPS+MB Sep-25 |
|
|---|---|---|---|---|---|---|---|
| Current accounts | 2,659 | 2,832 | 2,870 | 2,968 | 3.4% | 11.6% | 5,958 |
| Medium-long term loans | 50,705 | 52,041 | 53,173 | 53,657 | 0.9% | 5.8% | 82,753 |
| Other forms of lending | 15,023 | 14,890 | 15,483 | 15,004 | -3.1% | -0.1% | 36,423 |
| Reverse repurchase agreements | 7,035 | 7,029 | 7,251 | 7,409 | 2.2% | 5.3% | 13,398 |
| Impaired loans | 1,887 | 1,838 | 1,753 | 1,668 | -4.9% | -11.6% | 2,147 |
| Total | 77,310 | 78,631 | 80,530 | 80,705 | 0.2% | 4.4% | 140,679 |
| Dec-24 | Mar-25 | Jun-25 | Sep-25 | QoQ% | YtD% | MPS+MB Sep-25 |
|
|---|---|---|---|---|---|---|---|
| Current accounts | 67,180 | 65,736 | 67,753 | 69,189 | 2.1% | 3.0% | 91,299 |
| Time deposits | 7,151 | 7,546 | 7,574 | 7,603 | 0.4% | 6.3% | 16,996 |
| Repos | 6,800 | 9,101 | 6,578 | 7,068 | 7.5% | 3.9% | 9,857 |
| Bonds | 10,428 | 9,707 | 10,280 | 10,399 | 1.2% | -0.3% | 42,981 |
| Other forms of direct funding | 2,413 | 2,504 | 2,324 | 2,579 | 11.0% | 6.9% | 4,101 |
| Total | 93,972 | 94,594 | 94,509 | 96,838 | 2.5% | 3.1% | 165,235 |

Have a question? We'll get back to you promptly.